News

The Pharma Letter20h
Celltrion debuts its denosumab biosimilars in USA
The US subsidiary of South Korea-based Celltrion today announced that Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo) ...
Contract Pharma20h
Celltrion USA Launches Denosumab Biosimilars in the U.S.
Celltrion USA announced that Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo), biosimilars referencing Prolia ...